跳至主要内容
临床试验/NCT01406600
NCT01406600Unknown不适用

Optimal rhCG(Ovidrel®) Dose for Final Oocyte Maturation Triggering in Poor Responder During IVF and ICSI Cycles

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
70
试验地点
1
主要终点
oocyte maturity

研究概览

简要总结

Choriogonadotropin alfa (Ovidrel®) is a recombinant hCG (rhCG) preparation derived from genetically engineered Chinese hamster ovary cells, which is widely used for final oocyte maturation triggering in assisted reproductive technology (ART).Recombinant hCG has been investigated about its safety and efficacy comparing with urinary hCG, but still the optimal dose of rhCG is questionable. From former studies, there only have been proven that high dose of hCG can make ovarian hyperstimulation syndrome (OHSS) in usual condition. On the other hand, we hypothesize that high dose of hCG may improve oocyte maturity in poor responders who cannot easily provoke OHSS. Hence, this study will assess the comparative efficacy and safety of 250mcg and 500mcg of rhCG in ART treatment cycle.

详细描述

Randomized prospective clinical study that compare the two doses of rhCG (250mcg vs. 500mcg).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 44 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • poor response in prior IVF cycle (≤ 4 oocyte retrieved)
  • women's age ≥ 40 years
  • FSH ≥ 10mIU/mL or AMH ≤ 1.1ng/mL
  • Antral follicle count <6

排除标准

  • patient without informed consent

研究组 & 干预措施

rhCG 250mcg

Active Comparator

For final oocyte maturation triggering in ART, rhCG 250mcg will be administrated.

干预措施: recombinant hCG (Ovidrel®) (Drug)

rhCG 500mcg

Experimental

For final oocyte maturation triggering in ART, rhCG 500mcg will be administrated.

干预措施: recombinant hCG (Ovidrel®) (Drug)

结局指标

主要结局

oocyte maturity

时间窗: Up to the ovum pick up day. At the point of ovum pick-up, we can count how many mature or immature oocytes were retrived. Therefore, in one hour after ovum pick-up, outcome measurement will be possible.

After administration of different doses of rhCG, oocyte maturity will be assessed on ovum pick up day. Oocytes will be classified into GV, MI, and MII.

次要结局

  • clinical pregnancy rate(After confirming fetal heart beat via transvaginal ultrasound. Usually 2 to 4 weeks after ovum pick-up day.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Seok Hyun Kim

Seok Hyun Kim

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Optimal rhCG(Ovidrel®) Dose in Poor Responder During... | 临床试验